TRPV4 encodes a broadly expressed polymodal Ca2+-permeable channel and germline heterozygous dominant mutations across this gene have been identified in a wide range of diseases, but not in GCLJ or related bone disorders (Supplementary Fig. 2)14. Here, TRPV4 is linked to bone disorder.